For years, pharmaceutical companies have relied on a familiar model for sampling: field representatives introduce products, educate healthcare professionals (HCPs), and provide samples as part of a wider clinical conversation.
Over the past few years, we’ve seen sampling become increasingly strategic. Every sample carries a cost, making precision more important than ever. Pharmaceutical companies are becoming more selective about where, when and how they invest, focusing on delivering samples where they can have the greatest impact.
At the same time, access to HCPs is becoming more fragmented.
Field representatives face increasing challenges securing face-to-face time with HCPs. Conferences remain valuable but are often local and time-limited.
Many HCPs have limited availability, changing preferences for engagement, or simply don’t fit neatly into a traditional field model.
The question is no longer whether push or pull sampling is better.
The question is how to use both effectively.
Rep-triggered (“push”) sampling remains incredibly powerful. Representatives provide education, context and trusted relationships that digital channels alone cannot replace.
Equally, HCP-triggered (“pull”) sampling gives healthcare professionals the flexibility to access samples and materials whenever they need them, particularly where in-person engagement is limited.
These aren’t competing models.
They’re complementary.
SampleCupboard Rep enables compliant, efficient rep-triggered sampling, allowing field teams to spend less time managing logistics and more time engaging healthcare professionals.
SampleCupboard HCP extends that reach by enabling HCPs to request samples and materials directly, ensuring important audiences remain supported even when traditional field access is constrained.
Together, they create a more complete approach to HCP engagement.
Having both push and pull capabilities is only part of the answer.
The real opportunity lies in understanding when each approach should be used.
Which healthcare professionals benefit most from rep-triggered sampling, supported by personal field engagement and product education?
Which are ready to move to HCP-triggered, self-service sampling, giving them the flexibility to request samples whenever they need them?
And just as importantly, when should that engagement model change?
Rather than managing fixed target lists, organisations have the opportunity to continuously optimize practitioner engagement over time.
For example, a healthcare professional may initially require rep-led engagement and product education. As they become more familiar with a product and begin requesting samples independently, they could transition to a pull model, allowing field teams to focus their time on engaging new or higher-priority practitioners.
Where client sales data and field engagement data are available, SampleCupboard can support this optimisation by analyzing sampling activity across both rep-triggered and HCP-triggered channels. Combined with field insights and commercial objectives, this creates the opportunity to develop dynamic target lists, continuously refining who receives support, when, and through which channel.
Rather than treating sampling as a one-off distribution activity, organisations can use it as an evolving engagement strategy – one that adapts alongside practitioner behaviour and commercial priorities.
The future of sampling isn’t about choosing between push and pull.
It’s about orchestrating both.
The competitive advantage no longer comes from simply having multiple engagement channels. It comes from understanding when each channel creates the greatest value.
As healthcare professional engagement continues to evolve, the organisations achieving the greatest impact will be those that combine flexibility, precision and continuous optimisation – using insight to determine the most appropriate engagement model for every healthcare professional.
Strategic sampling is no longer just about distributing more samples.
It’s about continuously optimising how healthcare professionals engage with your products.
Find out more about our SampleCupboard strategic fulfilment solution.
Jump to a slide with the slide dots.
Discover how Inizio Engage helped a rare disease biotech reduce commercial launch risk through HCP mapping, referral pathway analysis and...
Leer más
Discover how AI, customer experience, and intelligent field teams are reshaping HCP engagement strategies across the pharmaceutical product lifecycle.
Leer más
Discover how learning systems, AI, and continuous optimisation are transforming pharmaceutical commercial strategy and HCP engagement.
Leer más